EP0708639A4 - METHODS AND COMPOSITIONS FOR TREATING DEPRESSION AND OTHER CONDITIONS WITH OPTICALLY PURE SIBUTRAMINE (+) - Google Patents

METHODS AND COMPOSITIONS FOR TREATING DEPRESSION AND OTHER CONDITIONS WITH OPTICALLY PURE SIBUTRAMINE (+)

Info

Publication number: EP0708639A4
Authority: EP; European Patent Office
Prior art keywords: compositions; conditions; methods; optically pure; treating depression
Prior art date: 1992-06-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP93915449A

Other languages

German (de)

French (fr)

Other versions

EP0708639A1 (en

Inventor

James W Young

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sumitomo Pharma America Inc

Original Assignee

Sepracor Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-06-23

Filing date

1993-06-22

Publication date

1997-08-20

1993-06-22 Application filed by Sepracor Inc filed Critical Sepracor Inc

1996-05-01 Publication of EP0708639A1 publication Critical patent/EP0708639A1/en

1997-08-20 Publication of EP0708639A4 publication Critical patent/EP0708639A4/en

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

EP93915449A 1992-06-23 1993-06-22 METHODS AND COMPOSITIONS FOR TREATING DEPRESSION AND OTHER CONDITIONS WITH OPTICALLY PURE SIBUTRAMINE (+) Withdrawn EP0708639A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US90303492A	1992-06-23	1992-06-23
US903034		1992-06-23
PCT/US1993/005967 WO1994000047A1 (en)	1992-06-23	1993-06-22	Methods and compositions for treating depression and other disorders using optically pure (+) sibutramine

Publications (2)

Publication Number	Publication Date
EP0708639A1 EP0708639A1 (en)	1996-05-01
EP0708639A4 true EP0708639A4 (en)	1997-08-20

Family

ID=25416828

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP93915449A Withdrawn EP0708639A4 (en)	1992-06-23	1993-06-22	METHODS AND COMPOSITIONS FOR TREATING DEPRESSION AND OTHER CONDITIONS WITH OPTICALLY PURE SIBUTRAMINE (+)

Country Status (5)

Country	Link
EP (1)	EP0708639A4 (en)
JP (1)	JPH07508281A (en)
AU (1)	AU4542993A (en)
CA (1)	CA2139000A1 (en)
WO (1)	WO1994000047A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020006964A1 (en) *	1995-05-16	2002-01-17	Young James W.	Methods of using and compositions comprising (+) sibutramine optionally in combination with other pharmacologically active compounds
DE19518988A1 (en) *	1995-05-29	1996-12-05	Basf Ag	Use of aryl substituted cyclobutylalkylamines to treat obesity
GB9619962D0 (en) *	1996-09-25	1996-11-13	Knoll Ag	Medical treatment
US6476078B2 (en)	1999-08-11	2002-11-05	Sepracor, Inc.	Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6331571B1 (en)	1998-08-24	2001-12-18	Sepracor, Inc.	Methods of treating and preventing attention deficit disorders
US6974838B2 (en)	1998-08-24	2005-12-13	Sepracor Inc.	Methods of treating or preventing pain using sibutramine metabolites
US6339106B1 (en)	1999-08-11	2002-01-15	Sepracor, Inc.	Methods and compositions for the treatment and prevention of sexual dysfunction
US6046242A (en) *	1998-11-27	2000-04-04	Basf Aktiengesellschaft	Use of aryl-substituted cyclobutylalkylamines for treating urinary incontinence
US6197828B1 (en) *	1998-12-01	2001-03-06	Sepracor, Inc.	Derivatives of (+)-venlafaxine and methods of preparing and using the same
US6342533B1 (en) *	1998-12-01	2002-01-29	Sepracor, Inc.	Derivatives of (−)-venlafaxine and methods of preparing and using the same
US6323242B1 (en)	1998-12-02	2001-11-27	Peter Sterling Mueller	Treatment of disorders secondary to organic impairments
US6696495B2 (en)	1998-12-02	2004-02-24	Snowden Pharmaceuticals, Llc	Treatment of disorders secondary to organic impairments
IL145238A0 (en) *	1999-03-19	2002-06-30	Knoll Gmbh	Treatment of osteoarthritis
DE60039132D1 (en)	1999-04-06	2008-07-17	Sepracor Inc	O-desmethylvenlafaxine succinate
RU2238084C2 (en) *	1999-08-11	2004-10-20	Сепракор Инк.	Compositions comprising inhibitors of dopamine re-uptake and methods for their using
US6399826B1 (en)	1999-08-11	2002-06-04	Sepracor Inc.	Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
US20020115727A1 (en) *	2000-12-04	2002-08-22	Senanayake Chris H.	Synthesis, methods of using, and compositions of hydroxylated cyclobutylalkylamines
EP1864967A1 (en)	2001-02-12	2007-12-12	Wyeth	Method for preparing O-desmethyl-venlafaxine
US6610887B2 (en)	2001-04-13	2003-08-26	Sepracor Inc.	Methods of preparing didesmethylsibutramine and other sibutramine derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3008993A1 (en) *	1980-03-08	1981-10-01	Röhm Pharma GmbH, 6100 Darmstadt	PHARMACEUTICAL PREPARATIONS
GB2098601B (en) *	1981-04-02	1985-07-24	Sandoz Products Ltd	Improvements in or relating to organic compounds
ZA821577B (en) *	1981-04-06	1983-03-30	Boots Co Plc	Therapeutic agents
GB8531071D0 (en) *	1985-12-17	1986-01-29	Boots Co Plc	Therapeutic compound
JP2675573B2 (en) *	1988-03-31	1997-11-12	科研製薬株式会社	Brain function improver

1993
- 1993-06-22 AU AU45429/93A patent/AU4542993A/en not_active Abandoned
- 1993-06-22 CA CA002139000A patent/CA2139000A1/en not_active Abandoned
- 1993-06-22 EP EP93915449A patent/EP0708639A4/en not_active Withdrawn
- 1993-06-22 JP JP6502537A patent/JPH07508281A/en active Pending
- 1993-06-22 WO PCT/US1993/005967 patent/WO1994000047A1/en not_active Ceased

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO9400047A1 *

Also Published As

Publication number	Publication date
JPH07508281A (en)	1995-09-14
EP0708639A1 (en)	1996-05-01
AU4542993A (en)	1994-01-24
WO1994000047A1 (en)	1994-01-06
CA2139000A1 (en)	1994-01-06

Similar Documents

Publication	Publication Date	Title
EP0708639A4 (en)	1997-08-20	METHODS AND COMPOSITIONS FOR TREATING DEPRESSION AND OTHER CONDITIONS WITH OPTICALLY PURE SIBUTRAMINE (+)
EP0647134A4 (en)	1997-07-30	METHODS AND COMPOSITIONS USED TO TREAT DEPRESSION AND OTHER CONDITIONS WITH OPTICALLY PURE SIBUTRAMINE (-).
DK0719165T3 (en)	1999-06-23	Practical "removable" respirator
EP1027045A4 (en)	2004-12-08	METHODS AND COMPOSITIONS FOR REGULATING 5-ALPHA-REDUCTASE ACTIVITY
MA23166A1 (en)	1994-12-31	METHODS OF USING HESPERETINE FOR SEBUM CONTROL AND THE TREATMENT OF ACNE.
FR2737122B1 (en)	1997-09-12	STABLE COMPOSITION CONTAINING ASCORBIC ACID
EP0746301A4 (en)	1996-02-07	SELF-TANNING COSMETIC COMPOSITIONS AND METHOD OF USING THE SAME
FI951701L (en)	1995-04-10	Methods for identifying Alzheimer's disease
EP0939835A4 (en)	2004-10-27	COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS
DE69524365D1 (en)	2002-01-17	Process for the isolation and purification of 2'-deoxy-2 ', 2'-difluoronucleosides
AU3590897A (en)	1999-01-04	Traveler's quarters
EP0716603A4 (en)	2000-10-04	METHODS AND COMPOSITIONS FOR INHIBITING URIDIN SECRETION
EP0730453A4 (en)	1998-03-04	METHODS OF TREATING CARDIAC ARRHYTHMIA
IL105216A0 (en)	1993-07-08	Method and kit for the diagnosis of alzheimer's disease
EP0705105A4 (en)	1998-12-30	METAL CHELATES FOR USE AS SPACING COMPOUNDS IN BIOLOGICALLY ACTIVE PEPTIDES
DE69405919D1 (en)	1997-11-06	Compositions for the treatment of keratin fibers
IT1271567B (en)	1997-05-30	PROCEDURE FOR THE FURTHER TREATMENT OF SALCICCE
ITBO950012A0 (en)	1995-01-19	LIQUID SUPPLEMENT FOR THE ENRICHMENT OF FERTILIZERS AND FERTILIZERS
DE69413289D1 (en)	1998-10-22	Procedure for reducing the "SNMP" instrumentation message flow
FR2757179B1 (en)	1999-01-08	PROCESS FOR THE PREPARATION OF AMIDES OF ACRYLIC OR METHACRYLIC ACID
MD145B1 (en)	1995-01-30	Brendi "botna" drink
DE69424475D1 (en)	2000-06-21	Process for the preparation of 1- (2'-deoxy-beta-D-erythropentofuranosyl) -5-trifluoromethyluracil derivatives
EP0979234A4 (en)	2002-10-30	METHODS AND COMPOSITIONS APPLICABLE TO THE DIAGNOSIS AND TREATMENT OF NEUROPSYCHIATRIC DISORDERS
ITMI921784A1 (en)	1994-01-23	PROCEDURE FOR THE REMOVAL OF VOLATILE COMPONENTS FROM SOLUTIONS CONTAINING POLYPHENYLENETERS
EP0692965A4 (en)	1998-08-12	METHOD AND COMPOSITION FOR THE TREATMENT OF OSTEOPOROSIS

Legal Events

Date	Code	Title	Description
1996-03-15	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1996-05-01	17P	Request for examination filed	Effective date: 19950118
1996-05-01	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
1997-03-19	RHK1	Main classification (correction)	Ipc: A61K 31/135
1997-08-20	A4	Supplementary search report drawn up and despatched	Effective date: 19970704
1997-08-20	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
2000-01-05	17Q	First examination report despatched	Effective date: 19991119
2002-12-18	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: SEPRACOR INC.
2005-05-20	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2005-07-06	18D	Application deemed to be withdrawn	Effective date: 20050101